MedTrace Logo

Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey

NCT06098963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2023-10-25

No results posted yet for this study

Summary

to report our patients' outcomes of SNM in tertiary health centres in Turkey

Conditions

  • Sacral Neuromodulation

Interventions

DEVICE

sacral neuromodulation

sacra neuromodulator implantation outcomes

Sponsors & Collaborators

  • Cigli Regional Training Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-01-01
Completion
2023-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06098963 on ClinicalTrials.gov